VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 20,500 shares of the company’s stock, valued at approximately $632,000.
Several other large investors also recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. raised its stake in Oscar Health by 107.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock valued at $79,867,000 after acquiring an additional 1,341,716 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Oscar Health by 22.1% during the first quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company’s stock valued at $48,078,000 after purchasing an additional 759,837 shares during the last quarter. Halter Ferguson Financial Inc. boosted its position in Oscar Health by 93.3% during the third quarter. Halter Ferguson Financial Inc. now owns 1,211,825 shares of the company’s stock worth $37,373,000 after purchasing an additional 584,818 shares during the period. Wedge Capital Management L L P NC purchased a new position in shares of Oscar Health in the second quarter worth about $32,855,000. Finally, Bank of America Corp DE increased its stake in shares of Oscar Health by 205.1% in the first quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after purchasing an additional 1,922,732 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.
Oscar Health Price Performance
NYSE OSCR traded down $2.44 during trading hours on Friday, hitting $30.74. The company had a trading volume of 8,874,950 shares, compared to its average volume of 4,643,670. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market capitalization of $9.49 billion, a price-to-earnings ratio of 12.70, a PEG ratio of 0.34 and a beta of 2.56. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $38.50. The firm has a 50 day simple moving average of $31.81 and a 200 day simple moving average of $23.97.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.63. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.69 billion. During the same period in the prior year, the business posted ($0.53) earnings per share. The company’s revenue was up 72.1% on a year-over-year basis. Equities research analysts expect that Oscar Health, Inc. will post 1.83 earnings per share for the current year.
Insider Activity at Oscar Health
In related news, Director Vanessa Wittman sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $32.24, for a total transaction of $806,000.00. Following the sale, the director owned 112,121 shares of the company’s stock, valued at approximately $3,614,781.04. This represents a 18.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Liang sold 10,360 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $325,822.00. Following the completion of the sale, the insider owned 248,697 shares in the company, valued at $7,821,520.65. This represents a 4.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 874,451 shares of company stock valued at $26,761,671 in the last quarter. 22.64% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the stock. Wells Fargo & Company boosted their price target on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. Piper Sandler cut their price objective on shares of Oscar Health from $48.00 to $45.00 and set an “overweight” rating for the company in a report on Friday. Weiss Ratings upgraded shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Barclays boosted their target price on shares of Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a report on Thursday, September 17th. Finally, Stephens restated an “equal weight” rating and set a $34.00 target price on shares of Oscar Health in a research report on Thursday, September 17th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $34.60.
Get Our Latest Analysis on Oscar Health
Oscar Health News Roundup
Here are the key news stories impacting Oscar Health this week:
- Positive Sentiment: Oscar reported Q3 adjusted earnings of $0.49 per share, versus analysts’ expected loss, and revenue of $5.14 billion, topping the $4.69 billion estimate and rising 72.1% year over year. Oscar Health beats Q3 earnings and revenue estimates
- Positive Sentiment: The company raised its 2026 revenue outlook to $19 billion–$19.3 billion, above the $18.64 billion FactSet estimate, and increased its full-year earnings outlook. Management cited improving medical costs and operating efficiencies as supporting margin gains, with expansion expected to contribute to 2027 growth. Q3 earnings call highlights outlook and margin gains
- Positive Sentiment: Operational indicators were also encouraging: membership increased 27.2% to 2.69 million, the medical loss ratio improved to 84.0%, and Oscar swung to a $167.3 million profit. Oscar Health Q3 revenue and membership growth
- Positive Sentiment: Zacks added OSCR to its Rank #1 (Strong Buy) growth-stocks list, reflecting favorable quantitative signals. Zacks growth stocks list
- Negative Sentiment: Piper Sandler lowered its price target from $48 to $45, although it maintained an Overweight rating. The new target still implies substantial upside from the referenced $30.74 share price. Piper Sandler rating information
Oscar Health Company Profile
Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.
Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.
Featured Articles
- Five stocks we like better than Oscar Health
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
